17,261 trials
Colon Cancer · Colorectal Cancer · Rectal Cancer
Primary: Grade 3 or 4 Neutropenia — 16; 51 Participants — p=<0.0001
Peritoneal Cancer · Ovarian Cancer · Neoplasms, Ovarian
Primary: Best Biochemical Response (Cancer Antigen [CA-125]) — 6; 25; 56; 3 percentage of participants
Type 1 Diabetes
Primary: Pharmacokinetics of the PassPort(R) Transdermal Insulin Delivery System in Type 1 Diabetes Patients (Cmax) — 33.0 uU/mL
Diabetes Mellitus
Primary: Urinary Protein/Creatinine Ratio in Patients With Type 1 or 2 Diabetes. — 1.016; 0.955; 0.874 mg/g
Hyperlipidemia
Primary: Urinary Protein/Creatinine Ratio at Week 52 [LOCF] — 0.938; 1.082; 0.759 ratio
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Alanine Aminotransferase (ALT) — 0; 0 Participants
Pediculus Humanus Capitis · Head Lice
Primary: Clinical Cure — 30; 28; 35; 32 Participants
Meningitis · Meningococcal Infection · Neisseria Meningitidis
Primary: Percentage of Participants With Meningococcal Antibody Titers ≥ 8 After Each Vaccination — 59; 36; 65; 83 Percentage of Participants
Myelodysplastic Syndromes · Thrombocytopenia
Primary: Occurrence of a Clinically Significant Thrombocytopenic Event — 8; 4; 8 Participants
Heart Failure
Primary: C Max (Day 1, Dose 1) — 58; 243; 209 ng/mL
Atopic Dermatitis · Allergic Contact Dermatitis
Primary: Number of Patients Achieving an Improvement (Decrease) in IGA (Investigator Global Assessment) by Two or More Points — 2 participants
Schizophrenia
Primary: Mean Change From Baseline to Last Observation After Baseline in Composite Score on the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS)…
Bipolar I Depression
Primary: The Mean Change From Baseline to Endpoint (Week 8 or Last Observation After Baseline) in the 30 Item Inventory of Depressive Symptomatology Clinician Rated (IDS C30)…
Nicotine Dependence
Primary: Time to Relapse to Smoking in the 5-week Relapse Prevention Phase. — 14.5; 12.4 days
Atrial Fibrillation
Primary: Frequency (Occurrence Rates) of Major Bleeding Event — 0; 1.7; 3.2 Percentage of patients